These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8442209)

  • 1. Clinical study of crystalloid cardioplegia vs aspartate-enriched cardioplegia plus warm reperfusion for donor heart preservation.
    Richens D; Junius F; Hill A; Keogh A; Macdonald P; McGoldrick J; Spratt P
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1608-10. PubMed ID: 8442209
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative advantages of nondepolarizing solution to depolarizing University of Wisconsin solution in donor heart preservation.
    Sunamori M; Amano J; Miyamoto H; Shirai T; Suzuki A
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1613-7. PubMed ID: 8442211
    [No Abstract]   [Full Text] [Related]  

  • 3. Donor organ preservation in high-risk cardiac transplantation.
    Faggian G; Forni A; Mazzucco A
    Transplant Proc; 2004 Apr; 36(3):617-9. PubMed ID: 15110612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor blood perfusion improves myocardial recovery after heart transplantation.
    Rao V; Feindel CM; Weisel RD; Boylen P; Cohen G
    J Heart Lung Transplant; 1997 Jun; 16(6):667-73. PubMed ID: 9229297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopsy assessment of donor hearts prior to and during transplantation.
    Darracott-Canković S; Cory-Pearce R; Stovin PG; Wallwork T; Wheeldon D; English TA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2564-5. PubMed ID: 3274564
    [No Abstract]   [Full Text] [Related]  

  • 6. [New frontiers in myocardial preservation].
    Juffe Stein A
    Rev Esp Cardiol; 1995; 48 Suppl 7():24-8. PubMed ID: 8775811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial protection during heart transplantation using blood cardioplegia.
    Luciani GB; Faggian G; Forni A; Montalbano G; Chiominto B; Mazzucco A
    Transplant Proc; 1997 Dec; 29(8):3386-8. PubMed ID: 9414759
    [No Abstract]   [Full Text] [Related]  

  • 8. Resuscitation of non-beating donor hearts using continuous myocardial perfusion: the importance of controlled initial reperfusion.
    Osaki S; Ishino K; Kotani Y; Honjo O; Suezawa T; Kanki K; Sano S
    Ann Thorac Surg; 2006 Jun; 81(6):2167-71. PubMed ID: 16731148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of intracellular solutions for donor heart preservation.
    Hendry PJ; Labow RS; Keon WJ
    J Thorac Cardiovasc Surg; 1993 Apr; 105(4):667-73. PubMed ID: 8469000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ideal volume and perfusion pressure of cardioplegic solution during retrieval of donor heart graft.
    Apostolakis E; Akinosoglou K
    J Heart Lung Transplant; 2009 Jan; 28(1):114. PubMed ID: 19134544
    [No Abstract]   [Full Text] [Related]  

  • 11. Ischemically damaged heart after preservation by the cavitary two-layer method as a possible donor in rat heart transplantation.
    Kamoda Y; Fujino Y; Tanioka Y; Sakai T; Kuroda Y
    J Heart Lung Transplant; 2007 Dec; 26(12):1320-5. PubMed ID: 18096485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The meta-physiology of organ preservation.
    Mendler N
    J Heart Lung Transplant; 1992; 11(4 Pt 2):S192-5. PubMed ID: 1515439
    [No Abstract]   [Full Text] [Related]  

  • 13. Pretreatment of donors with endothelin receptor antagonist TAK-044 improves cardiac functional recovery following preservation with University of Wisconsin solution.
    Kaneda T; Zhang ZW; Ogawa T; Otaki M; Saga T
    Scand Cardiovasc J; 2002 Mar; 36(2):105-7. PubMed ID: 12028874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of organ preservation techniques on outcome of cardiac transplantation in the era of donor pool expansion.
    Livi U; Caforio AL; Guzzi G; Feltrin G; Boffa GM; Angelini A; Casarotto D
    Transplant Proc; 1997 Dec; 29(8):3382-3. PubMed ID: 9414757
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of donor lung injury in heart-beating versus non-heart-beating donors.
    Neyrinck AP; Van De Wauwer C; Geudens N; Rega FR; Verleden GM; Wouters P; Lerut TE; Van Raemdonck DE
    Eur J Cardiothorac Surg; 2006 Oct; 30(4):628-36. PubMed ID: 16942886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of blood-based and crystalloid cardiopneumoplegic solutions in heart and lung preservation for 24 hours: an ultrastructural morphometric study in dogs.
    Tédy G; Corbi P; Rabago G; Muneretto C; Pavie A; Chomette G; Cabrol C; Gandjbakhch I
    Transplant Proc; 1993 Jun; 25(3):2222-5. PubMed ID: 8516878
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of cold blood cardioplegia and cold crystalloid cardioplegia with or without magnesium].
    Kuraoka S; Orita H; Shimanuki T; Kohno M; Fukasawa M; Inui K; Washio M
    Rinsho Kyobu Geka; 1989 Apr; 9(2):173-5. PubMed ID: 9301915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ preserving effect of lidocaine administration in the model of orthotopic liver transplantation from non-heart-beating donors.
    Kusano T; Shiraishi M; Miyaguni T; Hara J; Muto Y
    Transplant Proc; 1996 Jun; 28(3):1928-9. PubMed ID: 8658950
    [No Abstract]   [Full Text] [Related]  

  • 19. Donor heart preservation with iloprost supplemented St. Thomas Hospital cardioplegic solution in isolated rat hearts.
    Dedeoglu BD; Aytac E; Suzer O; Balci H; Uzun H; Seymen P; Seymen HO
    Prostaglandins Leukot Essent Fatty Acids; 2008 Jun; 78(6):415-21. PubMed ID: 18583122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystalloid versus cold blood cardioplegia and cardiac troponin I release.
    Pichon H; Chocron S; Alwan K; Toubin G; Kaili D; Falcoz P; Latini L; Clement F; Viel JF; Etievent JP
    Circulation; 1997 Jul; 96(1):316-20. PubMed ID: 9236451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.